跳到正文
原文
STAT Pharma 医药频道· Ed Silverman·· 2026-10-16AI 评分30

STAT+ 人事动态:Xilio Therapeutics 任命 Yariv Houvras 为首席医学官

STAT+: Up and down the ladder: The latest comings and goings

AI 导读

Xilio Therapeutics 已任命 Yariv Houvras 为首席医学官。Houvras 此前在 Tubulis 担任临床与转化开发高级副总裁。该人事变动收录于 STAT+ 的医药行业人事专栏。

正文
Pharmalot Coming/Going STILL
Alex Hogan/STAT

By Ed Silverman

Oct. 16, 2026

Pharmalot Columnist, Senior Writer

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.

And here is our regular feature in which we highlight a different person each week. This time around, we note that Xilio Therapeutics hired Yariv Houvras as chief medical officer. Previously, he was senior vice president of clinical and translational development at Tubulis.

But all work and no play can make for a dull chief medical officer.

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Pharmalot Columnist, Senior Writer

    Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter and the afternoon Pharmalot newsletter.

来源:STAT Pharma 医药频道 · statnews.com